Navigation Links
23andMe identifies multiple genetic factors impacting development of nearsightedness
Date:3/14/2013

Mountain View, Calif. March 14, 2013 In the largest ever genome-wide association study on myopia, 23andMe, the leading personal genetics company, identified 20 new genetic associations for myopia, or nearsightedness. The company also replicated two known associations in the study, which was specific to individuals of European ancestry. The study included an analysis of genetic data and survey responses from more than 50,000 23andMe customers and demonstrates that the genetic basis of myopia is complex and affected by multiple genes.

Myopia is the most common eye disorder worldwide. In the United States, an estimated 30 to 40 percent of the adult population is nearsighted. Myopia is a refractive error that results primarily from increased axial length of the eye. The increased physical length of the eye relative to optical length causes images to be focused in front of the retina, resulting in blurred distance vision.

The study, titled "Genome-Wide Analysis Points to Roles for Extracellular Matrix Remodeling, the Visual Cycle, and Neuronal Development in Myopia" was published on February 28, 2013 in PLOS Genetics, an open-access, peer-reviewed journal.

Although environmental factors (such as level of education, outdoor exposure, reading, and "near work" or fine detail work that requires close focus of the eyes) are implicated in the development of myopia, it is well established that genetics play a substantial role as well. The identification of these 20 novel genetic associations shows that several new genetic pathways play a role in the development of human myopia, including extracellular remodeling, the visual cycle, eye and body growth, retinal neuron development and general neuronal development or signaling.

"This study highlights the potential importance of early neuronal development in the progression of myopia and opens the door for additional research into the complex interactions that underlie vision development," said Nicholas Eriksson, Ph.D., author and 23andMe principal scientist.

Based on the findings of this study, 23andMe has launched a new research survey designed to provide insights that may expand understanding of the genetics of eyesight more broadly.


'/>"/>

Contact: Kendra Brogden
kbrogden@wcgworld.com
714-335-7362
23andMe Inc.
Source:Eurekalert

Related biology news :

1. 23andMes Ancestry Composition reveals peoples ancestral origins going back 500+ years
2. 23andMe scientists receive more than $500,000 in National Institutes of Health funding
3. 23andMe Names Christine Castro, Neil Rothstein and Jonathan Ward to Leadership Positions
4. 23andMe opens its API to developers
5. 23andMe contributes to genetic discoveries related to male pattern baldness
6. 23andMe identifies 5 significant genetic associations for hypothyroidism
7. Sleator lab identifies single point mutation in Listeria monocytogenes
8. Genome-wide imaging study identifies new gene associated with Alzheimers plaques
9. Study identifies liver gene that regulates cholesterol and fat blood levels
10. La Jolla Institute identifies molecular switch enabling immune cells to better fight disease
11. New study identifies significance of co-infection in disease control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... MedNet,s significant achievements are the result of the company,s ... iMedNet eClinical , it,s comprehensive, easy-to-use and ... --> Key MedNet growth achievements in ...
(Date:1/13/2016)... York , January 13, 2016 ... Research has published a new market report titled - Biometric ... Trends, and Forecast, 2015 - 2023. According to the report, ... 2014 and is anticipated to reach US$1,625.8 mn by ... to 2023. In terms of volume, the biometric sensors ...
(Date:1/8/2016)... ANGELES and MANCHESTER, United Kingdom ... ("BBI"), a developer of innovative sensor-based diagnostic products, today announced ... financed by new and existing investors.  Proceeds from the financing ... SEM Scanner , a hand-held device for detecting early-stage pressure ... Ireland after receiving CE Mark approval. ...
Breaking Biology News(10 mins):
(Date:2/3/2016)... 2016   ViaCyte, Inc ., a leading, ... stem cell-derived islet replacement therapy for the treatment ... announced that ViaCyte and Janssen Biotech, Inc., one ... Johnson, have agreed to consolidate the assets of ... provides ViaCyte with an exclusive license to all ...
(Date:2/3/2016)... 2016  With the growing need for better ... underway, therapies such as monoclonal antibodies, recombinant protein ... of indications are in high demand. Conventionally expression ... and production of these therapeutics. However, due to ... costs, novel approaches and novel expression systems are ...
(Date:2/3/2016)... Feb. 3, 2016 Harvard Apparatus Regenerative ... company developing bioengineered organ implants for life-threatening conditions ... that CEO Jim McGorry , will present ... on Tuesday, February 9, 2016 at 8:00 ... . HART,s presentation will be webcast live ...
(Date:2/3/2016)... ... February 03, 2016 , ... Aerocom, a world-leading supplier of ... North American healthcare market. , Aerocom Healthcare, LLC will be based in Denver, ... provide new pneumatic tube systems or expand existing systems within the U.S. and ...
Breaking Biology Technology: